Tools & Technology
The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand
DiaSorin posted Q2 molecular revenues of €69.4 million, up 23 percent year over year from €56.6 million.
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
The funding is for the firm's SARS-CoV-2, pan-coronavirus, and multiplex SARS-CoV-2, influenza, and respiratory syncytial virus tests, according to BARDA.
Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates
The firm saw growth across both its life science and clinical diagnostics businesses due to gradual recovery from the pandemic and increased its guidance for 2021.
Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent
The firm saw increases in SARS-CoV-2, clinical, and genomic testing and processed approximately 2.8 million COVID-19 PCR tests.
During its annual strategic planning, the firm identified its expanding base of MDx instruments as an essential driver of increasing revenues.